30
Participants
Start Date
August 1, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Rifaximin
Both groups were treated with rifaximin for 14 days, during which follow-up records were reported by the subjects in the daily reference case report form. Methane and hydrogen breath tests were repeated 2 weeks after withdrawal.
Navy General Hospital, Beijing
OTHER
Air Force Military Medical University, China
OTHER
Beijing Tongren Hospital
OTHER
Beijing Friendship Hospital
OTHER
Beijing Chao Yang Hospital
OTHER
Beijing Tiantan Hospital
OTHER
The Luhe Teaching Hospital of the Capital Medical University
OTHER
China-Japan Friendship Hospital
OTHER
Beijing Aerospace General Hospital
OTHER
Beijing Jishuitan Hospital
OTHER
Peking University Third Hospital
OTHER
Peking Union Medical College Hospital
OTHER